"Updates on the Management of Type 2 Diabetes: A Review of
the 2023 ADA Guidelines" presented by Dr. Erin Yamanaka, PharmD, PGY1 Pharmacy, USC and Hayley Cliatt, PharmD, PGY1 Pharmacy. VA Greater Los Angeles

The overall goal is to provide an overview of the 2023 update to the American Diabetes Association (ADA) guidelines, focusing on treatment considerations for Type 2 Diabetes now emphasizing a “patient centered care approach”, while considering social determinants of health and preventing clinical inertia.